Since 1987, Vanderbilt University School of Medicine has joined other research sites around the U.S. in the search for a safe and effective vaccine to help prevent HIV. In 1999, Vanderbilt joined an international collaboration called the HIV Vaccine Trials Network (HVTN) funded through the National Institutes of Health (NIH). As part of HVTN, Vanderbilt collaborates with sites around the world to find a preventative HIV vaccine.
Our mission is to promote clinical trials that will lead to a safe effective preventive HIV vaccine that will work everywhere in the world.
One of the best ways to help is becoming a study participant. We are looking for healthy, uninfected people between the ages of 18-55 of both genders and all ethnic and racial backgrounds. Before you would enter a study, you would attend an education session that explains the study and answers all your questions. Participating in a study is completely voluntary and attending an education session does not obligate you to further participation.
If you would like to participate in a study, contact Kyle Rybczyk at (615) 322-5641.
If you are not interested in enrolling in a trial but would still like to help out, you can participate on our Community Advisory Board. The board is made up of community members that volunteer their time once a month to give us feedback into our program. They also go to community events to tell others about what we do. Lastly, they look over protocols and make sure the community is being well-represented in our research.
Vanderbilt HIV Vaccine Trials Unit
1161 21st Ave. South
Nashville, TN 37232
Want regular updates about the Vanderbilt HIV Vaccine Program? Check out our Facebook Page and Twitter account. We post regularly with pictures, event details, trial updates and more. It's a great way to share information about our work with your friends and family.